Azala

Mexico Pharmaceuticals Report - Q3 2025

Gorde:
Argitaratua izan da:Fitch Solutions Country Industry Reports (Third Quarter 2025), p. 1
Argitaratua:
Fitch Solutions Group Limited
Gaiak:
Mexico
Pharmaceuticals
Statistical data
Industrywide conditions
Market analysis
Industry analysis
Business forecasts
SWOT analysis
Pharmaceutical industry
Sarrera elektronikoa:Citation/Abstract
Full Text - PDF
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
Laburpena:Despite facing challenges in drug procurement and patent enforcement, Mexico's pharmaceutical industry is poised for sustained growth, fuelled by an increasing demand for advanced treatments for chronic diseases. As the second largest pharmaceutical market in Latin America, Mexico offers significant opportunities for companies developing innovative medications. Nonetheless, relatively low per capita spending on pharmaceuticals could limit the widespread adoption of patented drugs, potentially boosting the market share of generics. Government initiatives aimed at enhancing local drug manufacturing are expected to foster more international partnerships, particularly in the area of technological exchange.
ISSN:2976-4750
Baliabidea:ABI/INFORM Trade & Industry